Fenwal Didn't Infringe Blood Centrifuge Patent: Judge

Law360, New York (September 15, 2011, 6:13 PM EDT) -- A Massachusetts federal judge on Tuesday ended a long-running patent infringement dispute over blood processing technology, finding that Fenwal Inc.’s products did not infringe a Haemonetics Corp. patent.

U.S. District Judge Nathaniel M. Gorton granted Fenwal’s motion for summary judgment in both of the suits Haemonetics lodged against Fenwal in 2005 and 2009 seeking to protect the rights of U.S. Patent Number 6,705,983.

“Fenwal’s products do not infringe the ‘983 patent, either literally or under the doctrine of equivalents,” Judge Gordon said in his order....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Haemonetics Corp. v. Baxter Healthcare Corp. et al


Case Number

1:05-cv-12572

Court

Massachusetts

Nature of Suit

Patent

Judge

Nathaniel M. Gorton

Date Filed

December 21, 2005


Case Title

Haemonetics Corp. v. Fenwal, Inc.


Case Number

1:09-cv-12107

Court

Massachusetts

Nature of Suit

Patent

Judge

Nathaniel M. Gorton

Date Filed

December 13, 2009

Law Firms

Companies

Patents

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.